$5.57
-0.37-6.23%
Benzinga
Benzinga
Benzinga
수요일, 10월 14
Benzinga
© 2026 Benzinga | All Rights Reserved
Bioage Labs (BIOA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.64 | $-0.64 | $-0.73 | $-0.58 |
| Actual | $-0.58 | $-0.52 | $-0.72 | $-0.56 |
| Surprise | +9.38% | +18.8% | +1.37% | +3.45% |
| Revenue | ||||
| Estimate | $1.4M | $1.1M | $1.9M | $777500 |
| Actual | $2.5M | $2.8M | $3.1M | $2.1M |
| Surprise | +72.9% | +155.9% | +60.7% | +164.2% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.62 | $-0.66 | $-0.54 | $-0.54 |
| Revenue | ||||
| Consensus | $1.4M | $1.2M | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-0.58 | $-0.64 | 9.38 % |
| Q1 | May 8, 2026 | $-0.52 | $-0.64 | 18.8 % |
| Q4 | Mar 24, 2026 | $-0.72 | $-0.73 | 1.37 % |
| Q3 | Nov 6, 2025 | $-0.56 | $-0.58 | 3.45 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $2.45M | $1.42M | 72.9 % |
| Q1 | May 8, 2026 | $2.77M | $1.08M | 155.9 % |
| Q4 | Mar 24, 2026 | $3.08M | $1.92M | 60.7 % |
| Q3 | Nov 6, 2025 | $2.05M | $777.50K | 164.2 % |